Skip to main content
. 2005 Feb 24;102(11):4016–4021. doi: 10.1073/pnas.0404701102

Table 2. Real-time qRT-PCR analysis of TRKA mRNA levels in primary AML patient samples.

Cluster Nos. in cluster Nos. >2-fold Proportion >2-fold P value for 2-fold Nos. >5-fold Proportion >5-fold P value for 5-fold
1 12 1 0.083 1 1 0.083 1
2 17 3 0.176 1 0 0.000 1
3 18 9 0.500 0.0032 2 0.111 0.9989
4 15 2 0.133 1 0 0.000 1
5 42 0 0.000 1 0 0.000 1
6 8 1 0.125 1 0 0.000 1
7 18 1 0.056 1 0 0.000 1
8 12 0 0.000 1 0 0.000 1
9 21 10 0.476 0.0027 4 0.190 0.2675
10 23 5 0.217 0.9999 1 0.043 1
11 9 0 0.000 1 0 0.000 1
12 19 6 0.316 0.7945 3 0.158 0.5398
13 21 10 0.476 0.0027 7 0.333 0.0005
14 10 0 0.000 1 0 0.000 1
15 8 1 0.125 1 1 0.125 1
16 11 0 0.000 1 0 0.000 1

Numbers in cluster are the number of patient samples in each cluster. Numbers >2-fold (or 5-fold) are number of sample with TRKA mRNA levels ≥2-fold (or 5-fold) the level of expression in CD34 selected bone marrow cells. Proportion >2-fold (or 5-fold) is the percentage of samples in that cluster with >2-fold (or 5-fold) TRKA mRNA levels, relative to CD34+ bone marrow cells. P values are provided for the proportion of samples with a >2-fold (or >5-fold) increase in TRKA mRNA levels.